About Direvo Biotech
Direvo Biotech is a company based in Koln (Germany) founded in 2000 was acquired by Bayer in September 2008.. Direvo Biotech has raised $35.4 million across 3 funding rounds from investors including NRW.Bank, The DuPont Nutrition and Health and TVM Capital Life Science. Direvo Biotech offers products and services including Sustainable Betting Services, Biomass Innovation Services, and Community Environment Services. Direvo Biotech operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Koln, Germany
-
Sectors
Energy & Utilities
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Direvo Biotech
Direvo Biotech offers a comprehensive portfolio of products and services, including Sustainable Betting Services, Biomass Innovation Services, and Community Environment Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Offers eco-friendly sports betting with minimal environmental impact
Provides biomass-based solutions for sustainable facility designs
Delivers community-focused environmental initiatives for betting operations
Funding Insights of Direvo Biotech
Direvo Biotech has successfully raised a total of $35.4M across 3 strategic funding rounds. The most recent funding activity was a Series D round of $8.1 million completed in April 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series D — $8.1M
-
First Round
First Round
(26 Nov 2002)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2010 | Amount | Series D - Direvo Biotech | Valuation |
investors |
|
| Oct, 2007 | Amount | Series C - Direvo Biotech | Valuation |
investors |
|
| Nov, 2002 | Amount | Series B - Direvo Biotech | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Direvo Biotech
Direvo Biotech has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include NRW.Bank, The DuPont Nutrition and Health and TVM Capital Life Science. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Capital is invested in life science innovations for healthcare transformation.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Direvo Biotech
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Direvo Biotech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Direvo Biotech Comparisons
Competitors of Direvo Biotech
Direvo Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Direvo Biotech
When was Direvo Biotech founded?
Direvo Biotech was founded in 2000 and raised its 1st funding round 2 years after it was founded.
Where is Direvo Biotech located?
Direvo Biotech is headquartered in Koln, Germany. It is registered at Koln, North Rhine-westphalia, Germany.
Is Direvo Biotech a funded company?
Direvo Biotech is a funded company, having raised a total of $35.4M across 3 funding rounds to date. The company's 1st funding round was a Series B of $10.5M, raised on Nov 26, 2002.
What does Direvo Biotech do?
Developer of sustainable sports betting facilities using biomass technology. It integrates advanced biomass technology with modern sports betting infrastructure to promote environmentally responsible operations. The company collaborates with environmental scientists and industry experts to design facilities that minimize ecological impact while maximizing user experience. Services include establishing new environmental standards in sports betting, leveraging biomass advancements for energy and green building, and creating betting environments that positively contribute to the community and the planet. The focus is on green technology leadership, commitment to innovation in sustainable energy and construction, and a concentration on positive community impact through its projects.
Who are the top competitors of Direvo Biotech?
Direvo Biotech's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
What products or services does Direvo Biotech offer?
Direvo Biotech offers Sustainable Betting Services, Biomass Innovation Services, and Community Environment Services.
Who are Direvo Biotech's investors?
Direvo Biotech has 7 investors. Key investors include NRW.Bank, The DuPont Nutrition and Health, TVM Capital Life Science, Bankhaus Wölbern, and Mulligan BioCapital.